Product Images Jentadueto Xr

This is a chart showing the number of patients at risk using the drugs Linagliptin and Glimepiride. The chart displays the number of patients for each drug at different time intervals over a period of 70 minutes. There is no additional information provided.*

Each tablet is a combination of 2.5 mg of linagliptin and 1000 mg of metformin hydrochloride. No dosage information is available in this text. The tablets must not be split, crushed, dissolved, or chewed. The medication guide should be dispensed with the tablets. The tablets may be stored at a temperature between 15°C to 30°C (59°F to 86°F). The medication should be kept away from children. The pharmaceutical product is distributed by BoehringerIngelheim Pharmaceuticals. The rest of the text is not readable.*

This text is a product label for Jentadueto XR, an extended-release tablet containing 5mg of linagliptin and 1000mg of metformin hydrochloride. The dosage instructions and storage guidelines are also outlined, along with cautionary information about administering the medicine to children. The label also includes information on the distributor and the trademark licensee, Boehringer Ingelheim.*